BRCA1 tumor suppressor network: focusing on its tail
Open accessAbstract
Germline mutations of the BRCA1 tumor suppressor gene are a major cause of familial breast and ovarian cancer. BRCA1 plays critical roles in the DNA damage response that regulates activities of multiple repair and checkpoint pathways for maintaining genome stability. The BRCT domains of BRCA1 constitute a phospho-peptide binding domain recognizing a phospho-SPxF motif (S, serine; P, proline; × varies; F, phenylalanine). The BRCT domains are frequently targeted by clinically important mutations and most of these mutations disrupt the binding surface of the BRCT domains to phosphorylated peptides. The BRCT domain and its capability to bind phosphorylated protein is required for the tumor suppressor function of BRCA1. Through its BRCT phospho-binding ability BRCA1 forms at least three mutually exclusive complexes by binding to phosphorylated proteins Abraxas, Bach1 and CTIP. The A, B and C complexes, at lease partially undertake BRCA1's role in mechanisms of cell cycle checkpoint and DNA repair that maintain genome stability, thus may play important roles in BRCA1's tumor suppressor function.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Abraxas is a central adaptor protein in the BRCA1 A complex and contains domains needed for interactions with BRCA1 and other complex components.
“In the BRCA1 A complex, Abraxas appears to be a central adaptor protein, as it harbors several domains necessary for the interactions with BRCA1 and other components in the complex (Wang, 2012).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Wang, 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
RETRACTED: Human SIRT6 Promotes DNA End Resection Through CtIP Deacetylation
Kaidi, A., Weinert, B. T., Choudhary, C., & Jackson, S. P. (2010) · Science · doi:10.1126/science.1192049 · Cited by 366 · see citing works
RetractedThe DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368 · see citing works
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213 · see citing works
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713 · see citing works
The DNA Damage Response: Ten Years After
Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705 · see citing works
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459 · see citing works
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
Reyes-Turcu, F. E., Ventii, K. H., & Wilkinson, K. D. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082307.091526 · Cited by 1,396 · see citing works
Human CtIP promotes DNA end resection
Sartori, A. A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R., Lukas, J., & Jackson, S. P. (2007) · Nature · doi:10.1038/nature06337 · Cited by 1,362 · see citing works
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245 · see citing works
RNF8 Ubiquitylates Histones at DNA Double-Strand Breaks and Promotes Assembly of Repair Proteins
Mailand, N., Bekker‐Jensen, S., Kildegaard, H. F., Melander, F., Bártek, J., Lukas, C., & Lukas, J. (2007) · Cell · doi:10.1016/j.cell.2007.09.040 · Cited by 1,153 · see citing works
Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
Polo, S. E., & Jackson, S. P. (2011) · Genes & Development · doi:10.1101/gad.2021311 · Cited by 1,092 · see citing works
RNF8 Transduces the DNA-Damage Signal via Histone Ubiquitylation and Checkpoint Protein Assembly
Huen, M. S. Y., Grant, R. A., Manke, I. A., Minn, K. T., Yu, X., Yaffe, M. B., & Chen, J. (2007) · Cell · doi:10.1016/j.cell.2007.09.041 · Cited by 1,027 · see citing works
Role of Rpn11 Metalloprotease in Deubiquitination and Degradation by the 26 S Proteasome
Verma, R., Aravind, L., Oania, R. S., McDonald, W. H., Yates, J. R., Koonin, E. V., & Deshaies, R. J. (2002) · Science · doi:10.1126/science.1075898 · Cited by 994 · see citing works
BRCA1 and BRCA2: 1994 and beyond
Narod, S. A., & Foulkes, W. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1431 · Cited by 967 · see citing works
Doil, C., Mailand, N., Bekker‐Jensen, S., Ménard, P., Larsen, D. H., Pepperkok, R., Ellenberg, J., Panier, S., Durocher, D., Bártek, J., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.041 · Cited by 938 · see citing works
Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase
Kolas, N. K., Chapman, J. R., Nakada, S., Ylanko, J., Chahwan, R., Sweeney, F. D., Panier, S., Mendez, M., Wildenhain, J., Thomson, T. M., et al. (2007) · Science · doi:10.1126/science.1150034 · Cited by 900 · see citing works
Glickman, M. H., Rubin, D. M., Coux, O., Wefes, I., Pfeifer, G., Cjeka, Z., Baumeister, W. P., Fried, V. A., & Finley, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81603-7 · Cited by 899 · see citing works
The BRCT Domain Is a Phospho-Protein Binding Domain
Yu, X., Chini, C. C. S., He, M., Mer, G., & Chen, J. (2003) · Science · doi:10.1126/science.1088753 · Cited by 862 · see citing works
Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861 · see citing works
The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage
Stewart, G. S., Panier, S., Townsend, K., Al-Hakim, A., Kolas, N. K., Miller, E. S., Nakada, S., Ylanko, J., Olivarius, S., Mendez, M., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.042 · Cited by 757 · see citing works
Ubiquitylation and cell signaling
Haglund, K., & Đikić, I. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600808 · Cited by 736 · see citing works
A cryptic protease couples deubiquitination and degradation by the proteasome
Yao, T., & Cohen, R. E. (2002) · Nature · doi:10.1038/nature01071 · Cited by 727 · see citing works
Jensen, D. E., Proctor, M. L., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 725 · see citing works
Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response
Wang, B., Matsuoka, S., Ballif, B. A., Zhang, D., Smogorzewska, A., Gygi, S. P., & Elledge, S. J. (2007) · Science · doi:10.1126/science.1139476 · Cited by 695 · see citing works
Self-citationCantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00304-x · Cited by 674 · see citing works
RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites
Sobhian, B., Shao, G., Lilli, D. R., Culhane, A. C., Moreau, L. A., Xia, B., Livingston, D. M., & Greenberg, R. A. (2007) · Science · doi:10.1126/science.1139516 · Cited by 672 · see citing works
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
Wang, W. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2159 · Cited by 663 · see citing works
BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting
Manke, I. A., Lowery, D. M., Nguyen, A., & Yaffe, M. B. (2003) · Science · doi:10.1126/science.1088877 · Cited by 651 · see citing works
Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G. E., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 635 · see citing works
Hashizume, R., Fukuda, M., Maeda, I., Nishikawa, H., Oyake, D., Yabuki, Y., Ogata, H., & Ohta, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000881200 · Cited by 634 · see citing works
How the Fanconi Anemia Pathway Guards the Genome
Moldovan, G., & D’Andrea, A. D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134222 · Cited by 586 · see citing works
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
Deng, C. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl010 · Cited by 583 · see citing works
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B., & Yu, X. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.018 · Cited by 556 · see citing works
CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle
Yun, M. H., & Hiom, K. (2009) · Nature · doi:10.1038/nature07955 · Cited by 556 · see citing works
Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response
Kim, H., Chen, J., & Yu, X. (2007) · Science · doi:10.1126/science.1139621 · Cited by 540 · see citing works
Involvement of Brca1 in S-Phase and G 2 -Phase Checkpoints after Ionizing Irradiation
Xu, B., Kim, S., & Kastan, M. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3445-3450.2001 · Cited by 540 · see citing works
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Lee, J., Collins, K. M., Brown, A. L., Lee, C. H., & Chung, J. H. (2000) · Nature · doi:10.1038/35004614 · Cited by 529 · see citing works
Human CtIP Mediates Cell Cycle Control of DNA End Resection and Double Strand Break Repair
Huertas, P., & Jackson, S. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808906200 · Cited by 511 · see citing works
BRCA1 and its toolbox for the maintenance of genome integrity
Huen, M. S. Y., Sy, S. M.-H., & Chen, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2831 · Cited by 495 · see citing works
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing
Zhu, Q., Pao, G. M., Huynh, A. M., Suh, H., Tonnu, N. U., Nederlof, P. M., Gage, F. H., & Verma, I. M. (2011) · Nature · doi:10.1038/nature10371 · Cited by 486 · see citing works
Factors determining DNA double‐strand break repair pathway choice in G2 phase
Shibata, A., Conrad, S., Birraux, J., Geuting, V., Barton, O., Ismail, A., Kakarougkas, A., Meek, K., Taucher-Scholz, G., Löbrich, M., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.27 · Cited by 481 · see citing works
The novel functions of ubiquitination in signaling
Sun, L., & Chen, Z. J. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.02.005 · Cited by 465 · see citing works
CDK targets Sae2 to control DNA-end resection and homologous recombination
Huertas, P., Cortés‐Ledesma, F., Sartori, A. A., Aguilera, A., & Jackson, S. P. (2008) · Nature · doi:10.1038/nature07215 · Cited by 456 · see citing works
A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal
Lam, Y. A., Lawson, T. G., Velayutham, M., Zweier, J. L., & Pickart, C. M. (2002) · Nature · doi:10.1038/416763a · Cited by 446 · see citing works
Wang, B., & Elledge, S. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710061104 · Cited by 446 · see citing works
Self-citationThe DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
Levitus, M., Waisfisz, Q., Godthelp, B. C., Vries, Y. D., Hussain, S., Wiegant, W. W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M. A., Pals, G., et al. (2005) · Nature Genetics · doi:10.1038/ng1625 · Cited by 432 · see citing works
Chen, L., Nievera, C. J., Lee, A. Y., & Wu, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710245200 · Cited by 425 · see citing works
DNA end resection: Many nucleases make light work
Mimitou, E. P., & Symington, L. S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.017 · Cited by 417 · see citing works
HDACs link the DNA damage response, processing of double-strand breaks and autophagy
Robert, T., Vanoli, F., Chiolo, I., Shubassi, G., Bernstein, K. A., Rothstein, R. J., Botrugno, O. A., Parazzoli, D., Oldani, A., Minucci, S., et al. (2011) · Nature · doi:10.1038/nature09803 · Cited by 412 · see citing works
Yu, X., & Chen, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9478-9486.2004 · Cited by 410 · see citing works
Mutations in BRIP1 confer high risk of ovarian cancer
Rafnar, Þ., Gudbjartsson, D. F., Sulem, P., Jónasdóttir, Á., Sigurðsson, Á., Jónasdóttir, A., Besenbacher, S., Lundin, P., Stacey, S., Guðmundsson, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.955 · Cited by 406 · see citing works
Litman, R., Peng, M., Jin, Z., Zhang, F., Zhang, J., Powell, S., Andreassen, P. R., & Cantor, S. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.004 · Cited by 396 · see citing works
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia
Levran, O., Attwooll, C., Henry, R. T., Milton, K. L., Neveling, K., Rio, P., Batish, S. D., Kalb, R., Velleuer, E., Barral, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1624 · Cited by 370 · see citing works
Delivery of ubiquitinated substrates to protein-unfolding machines
Elsasser, S., & Finley, D. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-742 · Cited by 364 · see citing works
Powell, S. N., & Kachnic, L. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206678 · Cited by 364 · see citing works
Ruffner, H., Joazeiro, C. A. P., Hemmati, D., Hunter, T., & Verma, I. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081068398 · Cited by 359 · see citing works
E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages
Christensen, D. E., Brzovic, P. S., & Klevit, R. E. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1295 · Cited by 351 · see citing works
EMBRACE, Antoniou, A. C., Collaborators, G. S., HEBON, kConFab, SWE-BRCA, SQUAD, M., GENICA, Wang, X., Fredericksen, Z. S., et al. (2010) · Nature Genetics · doi:10.1038/ng.669 · Cited by 333 · see citing works
Limbo, O., Chahwan, C., Yamada, Y., de Bruin, R. A. M., Wittenberg, C., & Russell, P. R. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.009 · Cited by 322 · see citing works
Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes
Greenberg, R. A., Sobhian, B., Pathania, S., Cantor, S. B., Nakatani, Y., & Livingston, D. M. (2006) · Genes & Development · doi:10.1101/gad.1381306 · Cited by 308 · see citing works
PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2
Zhang, F., Fan, Q., Ren, K., & Andreassen, P. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0123 · Cited by 303 · see citing works
Wu-Baer, F., Lagrazon, K., Yuan, W., & Baer, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300249200 · Cited by 302 · see citing works
Cellular functions of the BRCA tumour-suppressor proteins
Boulton, S. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340633 · Cited by 292 · see citing works
BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIPPreprint
Yu, X., Fu, S., Lai, M., Baer, R. J., & Chen, J. (2006) · Genes & Development · doi:10.1101/gad.1431006 · Cited by 283 · see citing works
HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes
Bekker‐Jensen, S., Danielsen, J. M. R., Fugger, K., Gromova, I., Nerstedt, A., Lukas, C., Bártek, J., Lukas, J., & Mailand, N. (2009) · Nature Cell Biology · doi:10.1038/ncb2008 · Cited by 277 · see citing works
Dong, Y., Hakimi, M., Chen, X., Kumaraswamy, E., Cooch, N. S., Godwin, A. K., & Shiekhattar, R. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00424-6 · Cited by 274 · see citing works
BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair
Ismail, I. H., Andrin, C., McDonald, D., & Hendzel, M. J. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201003034 · Cited by 270 · see citing works
Zhang, Y., & Jasin, M. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1940 · Cited by 269 · see citing works
Morris, J. R., & Solomon, E. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh095 · Cited by 267 · see citing works
BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance
Drost, R., Bouwman, P., Rottenberg, S., Boon, U., Schut, E., Klarenbeek, S., Klijn, C. N., van der Heijden, I., van der Gulden, H. M. L., Wientjens, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.014 · Cited by 261 · see citing works
Common variants at 19p13 are associated with susceptibility to ovarian cancer
the Australian Ovarian Cancer Study Group, Bolton, K. L., Cancer), T. A. C. S. (., Tyrer, J. P., Song, H., Ramus, S. J., Notaridou, M., Jones, C., Sher, T., Gentry‐Maharaj, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.666 · Cited by 246 · see citing works
BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity
Shakya, R., Reid, L. J., Reczek, C. R., Cole, F., Egli, D., Lin, C.-S., deRooij, D. G., Hirsch, S., Ravi, K., Hicks, J. B., et al. (2011) · Science · doi:10.1126/science.1209909 · Cited by 244 · see citing works
Cantor, S., Drapkin, R., Zhang, F., Lin, Y., Han, J., Pamidi, S., & Livingston, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308717101 · Cited by 240 · see citing works
Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains
Rodriguez, M., Yu, X., Chen, J., & Songyang, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300407200 · Cited by 234 · see citing works
Hu, Y., Scully, R., Sobhian, B., Xie, A., Shestakova, E. A., & Livingston, D. M. (2011) · Genes & Development · doi:10.1101/gad.2011011 · Cited by 232 · see citing works
CtIP Links DNA Double-Strand Break Sensing to Resection
You, Z., Shi, L. Z., Zhu, Q., Wu, P., Zhang, Y.-W., Basilio, A., Tonnu, N., Verma, I. M., Berns, M. W., & Hunter, T. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.12.002 · Cited by 231 · see citing works
The BRCA1-RAP80 Complex Regulates DNA Repair Mechanism Utilization by Restricting End Resection
Coleman, K. A., & Greenberg, R. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213728 · Cited by 224 · see citing works
Cooper, E. M., Cutcliffe, C., Kristiansen, T. Z., Pandey, A., Pickart, C. M., & Cohen, R. E. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.27 · Cited by 223 · see citing works
Shao, G., Lilli, D. R., Patterson-Fortin, J., Coleman, K. A., Morrissey, D. E., & Greenberg, R. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807485106 · Cited by 218 · see citing works
CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response
Kim, H., Huang, J., & Chen, J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1277 · Cited by 212 · see citing works
Maytal‐Kivity, V., Reis, N., Hofmann, K., & Glickman, M. H. (2002) · BMC Biochemistry · doi:10.1186/1471-2091-3-28 · Cited by 211 · see citing works
Mechanisms, biology and inhibitors of deubiquitinating enzymes
Love, K. R., Catic, A., Schlieker, C. D., & Ploegh, H. L. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.43 · Cited by 211 · see citing works
Bridge, W. L., Vandenberg, C. J., Franklin, R., & Hiom, K. J. (2005) · Nature Genetics · doi:10.1038/ng1627 · Cited by 208 · see citing works
CtIP promotes microhomology-mediated alternative end joining during class-switch recombination
Lee-Theilen, M., Matthews, A. J., Kelly, D., Zheng, S., & Chaudhuri, J. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1942 · Cited by 193 · see citing works
Protein partners of deubiquitinating enzymes
Ventii, K., & Wilkinson, K. D. (2008) · Biochemical Journal · doi:10.1042/bj20080798 · Cited by 185 · see citing works
Wang, B., Hurov, K., Hofmann, K., & Elledge, S. J. (2009) · Genes & Development · doi:10.1101/gad.1770309 · Cited by 172 · see citing works
Self-citationMERIT40 facilitates BRCA1 localization and DNA damage repairPreprint
Feng, L., Huang, J., & Chen, J. (2009) · Genes & Development · doi:10.1101/gad.1770609 · Cited by 163 · see citing works
BACH1/FANCJ Acts with TopBP1 and Participates Early in DNA Replication Checkpoint Control
Gong, Z., Kim, J.-E., Leung, C. C. Y., Glover, J. N. M., & Chen, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.002 · Cited by 160 · see citing works
MERIT40 controls BRCA1–Rap80 complex integrity and recruitment to DNA double-strand breaksPreprint
Shao, G., Patterson-Fortin, J., Messick, T. E., Feng, D., Shanbhag, N. M., Wang, Y., & Greenberg, R. A. (2009) · Genes & Development · doi:10.1101/gad.1739609 · Cited by 154 · see citing works
BRCA2: a universal recombinase regulator
Thorslund, T., & West, S. C. (2007) · Oncogene · doi:10.1038/sj.onc.1210870 · Cited by 150 · see citing works
Nakamura, K. M., Kogame, T., Oshiumi, H., Shinohara, A., Sumitomo, Y., Agama, K., Pommier, Y. G., Tsutsui, K., Tsutsui, K., Hartsuiker, E., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000828 · Cited by 149 · see citing works
CCDC98 targets BRCA1 to DNA damage sites
Liu, Z., Wu, J., & Yu, X. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1279 · Cited by 148 · see citing works
HERC2 Is an E3 Ligase That Targets BRCA1 for Degradation
Wu, W., Sato, K., Koike, A., Nishikawa, H., Koizumi, H., Venkitaraman, A. R., & Ohta, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1304 · Cited by 145 · see citing works
A conserved pathway to activate BRCA1‐dependent ubiquitylation at DNA damage sites
Polanowska, J., Martin, J. S., García‐Muse, T., Petalcorin, M. I. R., & Boulton, S. J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601102 · Cited by 143 · see citing works
The ubiquitin E3 ligase activity of BRCA1 and its biological functions
Wu, W., Koike, A., Takeshita, T., & Ohta, T. (2008) · Cell Division · doi:10.1186/1747-1028-3-1 · Cited by 132 · see citing works
Analysis of the DNA Substrate Specificity of the Human BACH1 HelicaseAssociated with BreastCancer
Gupta, R., Sharma, S., Sommers, J. A., Jin, Z., Cantor, S. B., & Brosh, R. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501995200 · Cited by 131 · see citing works
Reid, L. J., Shakya, R., Modi, A. P., Lokshin, M., Cheng, J., Jasin, M., Baer, R. J., & Ludwig, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811203106 · Cited by 128 · see citing works
Chen, P., Liu, F., Cai, S., Lin, X., Li, A., Chen, Y., Gu, B., Lee, E. Y.-H. P., & Lee, W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3535-3542.2005 · Cited by 125 · see citing works
Ubc13/Rnf8ユビキチンリガーゼはDNS損傷に反応してRap80/Abraxas/Brca1/Brca1/Brcc36複合体のフォーカス形成を制御する
Wang, B., & Stephen, J. E. (2007) · Cited by 125 · see citing works
Self-citationFeng, L., Wang, J., & Chen, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135392 · Cited by 122 · see citing works
BRCA1 Is Required for Postreplication Repair after UV-Induced DNA Damage
Pathania, S., Nguyen, J., Hill, S. J., Scully, R., Adelmant, G., Marto, J. A., Feunteun, J., & Livingston, D. M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.09.002 · Cited by 120 · see citing works
The potential role of ubiquitin c-terminal hydrolases in oncogenesis
Fang, Y., Fu, D., & Shen, X. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.03.001 · Cited by 120 · see citing works
CtIP Mutations Cause Seckel and Jawad Syndromes
Qvist, P., Huertas, P., Jimeno, S., Nyegaard, M., Hassan, M. J., Jackson, S. P., & Børglum, A. D. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002310 · Cited by 120 · see citing works
Environmental signals and cell fate specification in premigratory neural crest
Dorsky, R. I., Moon, R. T., & Raible, D. W. (2000) · BioEssays · doi:10.1002/1521-1878(200008)22:8 · Cited by 111 · see citing works
Kumaraswamy, E., & Shiekhattar, R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00961-07 · Cited by 110 · see citing works
Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1
Cantor, S. B., & Guillemette, S. (2011) · Future Oncology · doi:10.2217/fon.10.191 · Cited by 106 · cited 2× · see citing works
“Bach1 enzyme activity as well as the BRCA1-FancJ interaction is essential for DNA repair, checkpoint activation and tumor suppression [29,89,90].”
BackgroundMorris, J. R., Pangon, L., Boutell, C., Katagiri, T., Keep, N. H., & Solomon, E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi476 · Cited by 106 · see citing works
Minding the gap: The underground functions of BRCA1 and BRCA2 at stalled replication forks
Nagaraju, G., & Scully, R. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.020 · Cited by 103 · see citing works
Reverse the curse—the role of deubiquitination in cell cycle control
Song, L., & Rapé, M. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.012 · Cited by 100 · see citing works
PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization
Sy, S. M.-H., Huen, M. S. Y., Zhu, Y., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016717 · Cited by 98 · see citing works
Differential regulation of JAMM domain deubiquitinating enzyme activity within the RAP80 complex
Patterson-Fortin, J., Shao, G., Bretscher, H., Messick, T. E., & Greenberg, R. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135319 · Cited by 85 · see citing works
BRCC36 Is Essential for Ionizing Radiation–Induced BRCA1 Phosphorylation and Nuclear Foci Formation
Chen, X., Arciero, C. A., Wang, C., Broccoli, D., & Godwin, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4194 · Cited by 82 · see citing works
Hu, X., Kim, J. A., Castillo, A., Huang, M. L. H., Liu, J., & Wang, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200857 · Cited by 73 · see citing works
Self-citationN Terminus of CtIP Is Critical for Homologous Recombination-mediated Double-strand Break Repair
Yuan, J., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.023424 · Cited by 66 · see citing works
The Fanconi Anemia/BRCA Signaling Pathway: Disruption in Cisplatin-Sensitive Ovarian Cancers
D’Andrea, A. D. (2003) · Cell Cycle · doi:10.4161/cc.2.4.413 · Cited by 66 · see citing works
Cooper, E. M., Boeke, J. D., & Cohen, R. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059667 · Cited by 65 · see citing works
Nikkilä, J., Coleman, K. A., Morrissey, D., Pylkäs, K., Erkko, H., Messick, T. E., Karppinen, S.-M., Amelina, A., Winqvist, R., & Greenberg, R. A. (2009) · Oncogene · doi:10.1038/onc.2009.33 · Cited by 63 · see citing works
Targeting the FANCJ–BRCA1 interaction promotes a switch from recombination to polη-dependent bypass
Xie, J., Litman, R., Wang, S., Peng, M., Guillemette, S., Rooney, T., & Cantor, S. B. (2010) · Oncogene · doi:10.1038/onc.2010.18 · Cited by 60 · see citing works
Glover, J. N. M. (2006) · Familial Cancer · doi:10.1007/s10689-005-2579-z · Cited by 57 · see citing works
Christensen, D. E., & Klevit, R. E. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07249.x · Cited by 50 · see citing works
Boulton, S. J. (2006) · Cell Cycle · doi:10.4161/cc.5.14.2930 · Cited by 48 · see citing works
Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor α
Yan, J., Kim, Y. S., Yang, X.-P., Michael, A., Koegl, M., & Jetten, A. M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1112 · Cited by 33 · see citing works
MDC1 is ubiquitylated on its tandem BRCT domain and directly binds RAP80 in a UBC13-dependent manner
Strauss, C., Halevy, T., Macarov, M., Argaman, L., & Goldberg, M. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.04.016 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Interplay of oxidative stress, cellular communication and signaling pathways in cancer
Iqbal, M. J., Kabeer, A., Abbas, Z., Siddiqui, H. A., Călina, D. C., Sharifi‐Rad, J., & Cho, W. C. S. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01398-5 · Cited by 426 · see citing works
“Breast cancer susceptibility gene 1 (BRCA1) plays a significant role in the genomic stability of cells in response to oxidative DNA damage [51].”
BackgroundBiomedical text mining and its applications in cancer research
Zhu, F., Patumcharoenpol, P., Zhang, C., Yang, Y., Chan, J., Meechai, A., Vongsangnak, W., & Shen, B. (2012) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2012.10.007 · Cited by 247 · see citing works
“Systems biomedicine carries on analysis and study from different levels, including motif [118,119], pathway [120–122], module [123– 125] and network [126,127].”
Balmus, G., Pilger, D., Coates, J., Demir, M., Sczaniecka-Clift, M., Barros, A. C., Woods, M., Fu, B., Yang, F., Chen, E. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07729-2 · Cited by 186 · see citing works
“C), their contributions to the phenotypes of BRCA1-deficient cells are poorly understood (Wang, 2012).”
BackgroundBRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies
Fu, X., Tan, W., Song, Q., Pei, H., & Li, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.813457 · Cited by 131 · see citing works
“The BRCT domain is conserved in several DNA damage response (DDR) proteins and is responsible for BRCA1 to recognize a phospho-SPxF motif (S, serine; P, proline; x, varies; F, phenylalanine) (Wang, 2012; Chabanon et al., 2021).”
BackgroundBRCA1 Promotes Unloading of the CMG Helicase from a Stalled DNA Replication Fork
Long, D. T., Joukov, V., Budzowska, M., & Walter, J. C. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.012 · Cited by 120 · see citing works
“…extracts were supplemented with recombinant BRCA1-BARD1 heterodimer (Joukov et al., 2006), helicase eviction was not restored (data not shown), suggesting that the activity of the complex is dependent on additional binding factors or specific modifications (Silver and Livingston, 2012; Wang, 2012).”
BackgroundMethodBreast cancer genes: beyond BRCA1 and BRCA2
Vega, A. (2013) · Frontiers in bioscience · doi:10.2741/4185 · Cited by 88 · see citing works
Wu, Q., Paul, A., Su, D., Mehmood, S., Foo, T. K., Ochi, T., Bunting, E. L., Xia, B., Robinson, C. V., Wang, B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2015.12.017 · Cited by 77 · see citing works
“Abraxas and the BRCA1-A complex recruit BRCA1 to DNA double-strand-break sites (DSBs) in an ATM-dependent ubiquitin-mediated signaling pathway involving E2 conjugase Ubc13, E3 ligases RNF8/RNF168, and Rap80 binding to ubiquitin lys63-linked polyubiquitin conjugates (Doil et al., 2009; Harper and Elledge, 2007; Hu et a…”
BackgroundSelf-citationHu, X., Paul, A., & Wang, B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374116 · Cited by 75 · see citing works
“GSTtagged or His-tagged SUMO2 and wild-type or mutant Rap80(1–129) were generated with pDEST15 (GST) and pDEST17 (His) vectors (Invitrogen) via the Gateway recombination system. siRNAs used for knocking down Rap80, Abraxas, BRE, and BRCC36 were described previously (9, 20, 21).”
BackgroundInfluentialSelf-citationRNF8- and Ube2S-Dependent Ubiquitin Lysine 11-Linkage Modification in Response to DNA Damage
Paul, A., & Wang, B. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.013 · Cited by 72 · see citing works
“We thus tested IR-induced foci formation (IRIF) of 53BP1 and Abraxas/BRCA1-A complex (Wang, 2012; Wang and Elledge, 2007; Wang et al., 2007) components in Ube2S/Ube2Cdepleted cells.”
MethodSelf-citationMechanism of BRCA1–BARD1 function in DNA end resection and DNA protection
Ceppi, I., Stritto, M. R. D., Mütze, M., Braunshier, S., Mengoli, V., Reginato, G., Võ, H. M. P., Jimeno, S., Acharya, A., Roy, M. M., et al. (2024) · Nature · doi:10.1038/s41586-024-07909-9 · Cited by 68 · see citing works
“C complex is cell-cycle regulated and it is dependent on protein phosphorylation 17,18,30 .”
BRCA1 in the DNA damage response and at telomeres
Rosen, E. M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00085 · Cited by 66 · see citing works
“Other components of BRCA1 complex A include BARD1, BRCC36, BRCC45, and NDA1 (MERIT40) (Fong et al., 2009; Wang, 2012).”
BackgroundXu, S., Wu, X. Y., Wu, L., Castillo, A., Liu, J., Atkinson, E., Paul, A., Su, D., Schlacher, K., Komatsu, Y., et al. (2017) · Genes & Development · doi:10.1101/gad.299172.117 · Cited by 65 · see citing works
“While Abraxas plays a critical role in double-strand break (DSB) repair by recruiting BRCA1 toDSBs and is important for tumor suppression (Hu et al. 2012;Wang 2012; Castillo et al. 2014), the role of Abro1 in genomemaintenance and tumor suppression is not clear.”
BackgroundSelf-citationFang, Y., Zhang, Q., Wang, X., YANG, X., Wang, X., Huang, Z., Jiao, Y., & Wang, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3327 · Cited by 65 · see citing works
“BRCA1 executes its functions by forming at least three different protein complexes (57).”
BackgroundNAD+ Metabolism in Aging and Cancer
Demarest, T. G., Babbar, M., Okur, M. N., Dan, X., Croteau, D. L., Fakouri, N. B., Mattson, M. P., & Bohr, V. A. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055905 · Cited by 57 · see citing works
Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice
Vasanthakumar, A., Arnovitz, S., Marquez, R., Lepore, J. B., Rafidi, G., Asom, A. S., Weatherly, M., Davis, E. M., Neistadt, B., Duszynski, R. J., et al. (2015) · Blood · doi:10.1182/blood-2015-03-635599 · Cited by 53 · see citing works
“Representative cell karyotype in G: 40,XX,chte(2;5)(F1;C2),chte(9;12)(F1;E),pcd(16)(A)[1].”
BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites
Hu, Z., Mi, S., Zhao, T. S., Peng, C., Peng, Y., Chen, L., Zhu, W., Yao, Y., Song, Q., Li, X., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104133 · Cited by 50 · see citing works
“Antibodies used in this study were as follows: BRCA1 (D-9, Santa Cruz, WB 1:500, IF 1:50) and (C-20, Santa Cruz, WB 1:500, IF 1:50), HA (H9658, Sigma, WB 1:2,000), FLAG (F3165, Sigma, WB 1:2,000), c H2AX (05-636, Millipore, WB 1:5,000, IF 1:1,000) and (A300-081A, Bethyl Laboratories, WB 1:1,000, IF 1:200), CtIP (61141…”
InfluentialBRCA1 and RNAi factors promote repair mediated by small RNAs and PALB2–RAD52
Hatchi, E., Goehring, L. J., Landini, S., Skourti-Stathaki, K., DeConti, D. K., Abderazzaq, F. O., Banerjee, P., Demers, T. M., Wang, Y. E., Quackenbush, J. F., et al. (2021) · Nature · doi:10.1038/s41586-020-03150-2 · Cited by 49 · see citing works
Henderson, B. R. (2012) · Scientifica · doi:10.6064/2012/796808 · Cited by 45 · see citing works
“ese are the BRCA1A (controls G2-M checkpoint and DNA repair), BRCA1B (DNA replication checkpoint), BRCA1-C (DNA resection and G2-M checkpoint), and BRCC (homologous recombination mediated DNA repair) complexes (reviewed recently in [6, 22, 77, 90, 91]).”
BackgroundThe BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression
Castillo, A., Paul, A., Sun, B., Huang, T. H., Wang, Y., Yazinski, S. A., Tyler, J., Li, L., You, M. J., Zou, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.050 · Cited by 39 · see citing works
“In the BRCA1 A complex, Abraxas appears to be a central adaptor protein, as it harbors several domains necessary for the interactions with BRCA1 and other components in the complex (Wang, 2012).”
BackgroundSelf-citationFactors forming the BRCA1-A complex orchestrate BRCA1 recruitment to the sites of DNA damage
Her, J., Lee, N. S., Kim, Y., & Kim, H. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw047 · Cited by 41 · see citing works
“BRCA1-B is composed of BRCA1, TopBP1, and BACH1, and is involved in DNA replication stress-induced checkpoint and DNA interstrand crosslink (ICL) repair [36].”
BackgroundBRCA1 and homologous recombination: implications from mouse embryonic development
Liu, Y., & Lu, L. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00412-4 · Cited by 41 · see citing works
Opportunities and hurdles in the treatment of BRCA1-related breast cancer
Drost, R., & Jonkers, J. (2013) · Oncogene · doi:10.1038/onc.2013.329 · Cited by 39 · see citing works
BRCA1 and Metastasis: Outcome of Defective DNA Repair
Krishnan, R., Patel, P. S., & Hakem, R. (2021) · Cancers · doi:10.3390/cancers14010108 · Cited by 36 · see citing works
Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by CezannePreprint
Wu, X. Y., Liu, S., Sagum, C. A., Chen, J., Singh, R. K., Chaturvedi, A., Horton, J. R., Kashyap, T. R., Fushman, D., Cheng, X., et al. (2019) · Genes & Development · doi:10.1101/gad.332395.119 · Cited by 33 · see citing works
“The UIM domains of Rap80, a component of the Abraxas/BRCA1-A complex, bind to K63-linked chains recruiting Rap80 and the BRCA1-A complex to DNA damage sites (Kim et al. 2007; Sobhian et al. 2007; Wang and Elledge 2007; Wang et al. 2007, 2009; Wang 2012).”
BackgroundSelf-citationIsmail, T., Alzneika, S., Riguene, E., Al-Maraghi, S., Alabdulrazzak, A., Al-Khal, N., Fetais, S., Thanassoulas, A., Farsi, H. F. A., & Nomikos, M. (2024) · Pharmaceuticals · doi:10.3390/ph17030333 · Cited by 32 · see citing works
“BRCA1 is a large multifunctional protein (1863 amino acids in size) composed of diverse domains essential for its important role in maintaining genomic stability and tumor suppression [5].”
BackgroundUbiquitin- and ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer
Voutsadakis, I. A. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2261-0 · Cited by 32 · see citing works
“BRCA1 cell cycle checkpoint control complexes have many participants in common with DNA damage repair [30] and thus SUMOylation is expected to Table 1 Examples of E2 enzymes playing a role in breast cancer, their target UBLs, co-operating E3s, target proteins modified and processes that are regulated”
BackgroundTwo redundant ubiquitin-dependent pathways of BRCA1 localization to DNA damage sites
Sherker, A., Chaudhary, N., Adam, S., Heijink, A. M., Noordermeer, S. M., Fradet‐Turcotte, A., & Durocher, D. (2021) · EMBO Reports · doi:10.15252/embr.202153679 · Cited by 28 · see citing works
“BRCA1-A is one of at least three BRCA1 protein complexes mediated by the tandem BRCT domain-dependent recognition of phosphorylated epitopes: BRCA1-B is formed by interaction with phospho-BACH1 and BRCA1-C is formed by interactions with phospho-CtIP (Wang, 2012).”
BackgroundSevcik, J., Falk, M., Macůrek, L., Kleiblová, P., Lhota, F., Hojny, J., Štefančíková, L., Janatová, M., Bártek, J., Stribrna, J., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.02.008 · Cited by 28 · see citing works
BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far
Sharma, B., Kaur, R. P., Raut, S., & Munshi, A. (2018) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2018.01.001 · Cited by 27 · see citing works
BRCA1 the Versatile Defender: Molecular to Environmental Perspectives
Zhong, A. X., Chen, Y., & Chen, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814276 · Cited by 25 · see citing works
“This domain establishes vital interactions with phosphorylated Abraxas, Bach1, and CtIP, culminating in the assembly of the A, B, and C-complexes, respectively (reviewed in [33]).”
Three-Dimensional Architecture of the Human BRCA1-A Histone Deubiquitinase Core Complex
Kyrieleis, O. J. P., McIntosh, P. B., Webb, S. R., Calder, L. J., Lloyd, J., Patel, N. A., Martin, S. R., Robinson, C. V., Rosenthal, P. B., & Smerdon, S. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.063 · Cited by 25 · see citing works
“A key player in HR repair is the tumor suppressor BRCA1 (breast cancer susceptibility protein 1), which, along with Bard1, is found in three distinct complexes (BRCA1-A, -B, and –C) that are distinguished by virtue of different phospho-dependent interactions of the Brca1 BRCT-repeats with pSPxF motifs in Abraxas (A),…”
BackgroundBRCA1–BARD1 combines multiple chromatin recognition modules to bridge nascent nucleosomes
Burdett, H., Foglizzo, M., Musgrove, L. J., Kumar, D., Clifford, G., Campbell, L. J., Heath, G. R., Zeqiraj, E., & Wilson, M. D. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad793 · Cited by 24 · see citing works
“( 23–30 ) .”
E3 ligases: a ubiquitous link between DNA repair, DNA replication and human disease
Chauhan, A. S., Jhujh, S. S., & Stewart, G. S. (2024) · Biochemical Journal · doi:10.1042/bcj20240124 · Cited by 23 · see citing works
Making Connections: Integrative Signaling Mechanisms Coordinate DNA Break Repair in Chromatin
Sanchez, A. R., Lee, D., Kim, D. I., & Miller, K. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.747734 · Cited by 22 · see citing works
“This complex consists of BRCA1, RAP80, BRCC36 and BRCC45, MERIT 40, and Abraxas (ABRA1) and is essential for controlling DSB repair efficiency by HR (Harris and Khanna, 2011; Wang, 2012; Rabl, 2020).”
BackgroundDOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair
Tang, H., Lu, Y.-F., Zeng, R., Liu, C., Shu, Y., Wu, Y., Su, J., Di, L., Qian, J., Zhang, J., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2320804121 · Cited by 19 · see citing works
Bellat, V., Verchère, A., Ashe, S. A., & Law, B. (2020) · BMC Cancer · doi:10.1186/s12885-020-07134-3 · Cited by 19 · see citing works
Wu, X. Y., & Wang, B. (2021) · Nature Communications · doi:10.1038/s41467-021-24665-w · Cited by 19 · see citing works
Self-citationGuerrero, J. P., Fernández-Rubio, C., García‐Sosa, A. T., & Nguewa, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071839 · Cited by 19 · see citing works
Karachaliou, N., Costa, C., Giménez-Capitán, A. A., Molina‐Vila, M. Á., Bertrán-Alamillo, J., Mayo, C., Massutí, B., Majem, M., Carcereny, E., Morán, T., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31827db621 · Cited by 19 · see citing works
Structural Basis for the BRCA1 BRCT Interaction with the Proteins ATRIP and BAAT1
Liu, X., & Ladias, J. A. A. (2013) · Biochemistry · doi:10.1021/bi400714v · Cited by 16 · see citing works
A porcine model system of BRCA1 driven breast cancer
Donninger, H., Hobbing, K. R., Schmidt, M., Walters, E. M., Rund, L. A., Schook, L., & Clark, G. J. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00269 · Cited by 15 · see citing works
The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer
Russi, M., Marson, D., Fermeglia, A., Aulić, S., Fermeglia, M., Laurini, E., & Pricl, S. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108009 · Cited by 13 · see citing works
Chang, C.-W., Singh, A. K., Li, M., Guan, L., Le, N., Omabe, K. N., Liang, F., & Liu, Y. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217542119 · Cited by 13 · see citing works
The BRCA1/BARD1 complex recognizes pre-ribosomal RNA to facilitate homologous recombination
Wu, D., Huang, H., Chen, T., Gai, X., Li, Q., Wang, C., Yao, J., Liu, Y., Cai, S., & Yu, X. (2023) · Cell Discovery · doi:10.1038/s41421-023-00590-8 · Cited by 13 · see citing works
“Interactions between BRCA1 and these binding partners form BRCA1 A, B, C complexes, respectively 20 .”
The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression
Chang, S., & Sharan, S. K. (2013) · Transcription · doi:10.4161/trns.22600 · Cited by 13 · see citing works
“Our current understanding of BRCA1’s function is based largely on the role of its interacting proteins.(3,4) The RING domain has been shown to interact with The role of epigenetic transcriptional regulation in BRCA1-mediated tumor suppression”
BackgroundGaboriau, D. C. A., Rowling, P. J. E., Morrison, C. G., & Itzhaki, L. S. (2015) · Biochemical Journal · doi:10.1042/bj20141077 · Cited by 12 · see citing works
Takata, K., Tomida, J., Reh, S., Swanhart, L. M., Takata, M., Hukriede, N. A., & Wood, R. D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677419 · Cited by 12 · see citing works
“Six of these (BRCA1, BRCA2, BARD1, PALB2, FANCJ, RBBP8/CtIP) are components of the A, B and C BRCA1associated complexes related to homologous recombination (41) (Fig.”
BackgroundTian, X., Liu, C., Wang, X., Wang, F., Wang, L., Xu, L., Ma, J., Gao, Y., Bao, Y., Wang, F., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0362-y · Cited by 11 · see citing works
Li, S., Tang, M., Xiong, Y., Feng, X., Wang, C., Nie, L., Huang, M., Zhang, H., Yin, L., Zhu, D., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03108-y · Cited by 9 · see citing works
“The BRCA1-B complex is involved in DNA replication stress-induced checkpoint control and ICL repair [25].”
InfluentialStructural insights into DNA double-strand break signaling
Panigrahi, R., & Glover, J. N. M. (2021) · Biochemical Journal · doi:10.1042/bcj20200066 · Cited by 8 · see citing works
Awate, S., Sommers, J. A., Datta, A., Nayak, S. U., Bellani, M. A., Yang, O., Dunn, C., Nicolae, C. M., Moldovan, G., Seidman, M. M., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa660 · Cited by 9 · see citing works
Sachsenweger, J., Jansche, R., Merk, T., Heitmeir, B., Deniz, M., Faust, U., Roggia, C., Tzschach, A., Schroeder, C., Rieß, A., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05845-6 · Cited by 8 · see citing works
“C complexes in S-and G2-phase of the cell cycle [14].”
Hamdi, Y., Leclerc, M., Dumont, M., Dubois, S., Tranchant, M., Reimnitz, G., Soucy, P., Cassart, P., Ouimet, M., Sinnett, D., et al. (2019) · Genes · doi:10.3390/genes10030186 · Cited by 8 · see citing works
A special issue on DNA damage response and genome stability
Li, G. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-4 · Cited by 7 · see citing works
“A second article by Bin Wang [11] describes how BRCA1, an important tumor suppressor and a critical DNA damage response mediator, interacts with its partners to regulate activities of multiple repair and checkpoint pathways for genome maintenance.”
BackgroundHaanpää, M. K. (2014) · Cited by 6 · see citing works
Bose, M., Sachsenweger, J., Laurila, N., Parplys, A. C., Willmann, J., Jungwirth, J., Groth, M., Rapakko, K., Nieminen, P. A., Friedl, T. W. P., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz252 · Cited by 6 · see citing works
“dependent manner, thus enabling interaction with BACH1 (BRIP1/FANCJ) and CtIP (RBBP8), resulting in the formation of BRCA1-B and BRCA1-C complexes, respectively (15).”
BackgroundDiouf, O. B., Gilbert, A., Bernay, B., Syljuåsen, R. G., Tudor, M., Temelie, M., Savu, D., Soumboundou, M., Sall, C., & Chevalier, F. (2024) · Proteomes · doi:10.3390/proteomes13010001 · Cited by 5 · see citing works
RNAi Screening Uncovers a Synthetic Sick Interaction between CtIP and the BARD1 Tumor Suppressor
Bolck, H. A., Przetocka, S., Meier, R., von Aesch, C., Zurfluh, C., Hänggi, K., Spegg, V., Altmeyer, M., Stebler, M., Nørrelykke, S. F., et al. (2022) · Cells · doi:10.3390/cells11040643 · Cited by 5 · see citing works
Park, D., Gharghabi, M., Reczek, C. R., Plow, R., Yungvirt, C., Aldaz, C. M., & Huebner, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073729 · Cited by 4 · see citing works
Kim, J. H., Yoon, H. J., Ha, H. I., Kim, E. T., Kim, D. E., Kim, S. I., Bae, J. K., & Lim, M. C. (2025) · Cancers · doi:10.3390/cancers17101661 · Cited by 3 · see citing works
“This result may be due to the multifunctional nature of BRCA1 , which contains other critical domains such as the RING and BRCT domains that facilitate interactions with various proteins involved in DNA damage response and repair [23,24].”
Ling, H., Li, S., Wu, Y. F., Zheng, Y.-Z., Qiao, F., Yao, L., Cao, Z.-G., Ye, F.-G., Wu, J., Hu, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7112 · Cited by 3 · see citing works
“BRCA1 suppresses malignant transformation at least partially through regulating the DNA damage response and maintaining genome stability [11, 12].”
Self-citationMorales, R., Serrano, R., Sardón, T., Román-Ortíz, C., González-Santiago, S., Mulet‐Lazaro, R., & Mas, J. M. (2017) · Journal of Cancer Genetics and Biomarkers · doi:10.14302/issn.2572-3030.jcgb-16-1307 · Cited by 1 · see citing works
“A number of other proteins also bind to the C-terminal region of BRCA1 and/or its central region (7) (Figure 1).”
Using Machine Learning Algorithms to find Novel Biomarkers for Breast Cancer using RNA-Seq DatasetPreprint
Abdul, A., Paudel, R., & Rahman, M. M. (2023) · Preprints.org · doi:10.20944/preprints202309.0006.v1 · Cited by 2 · see citing works
Harnessing DOT1L and RAP80: unveiling new insights into BRCA1-mediated DNA repair for cancer therapy
Li, P., & Yu, X. (2024) · Genome Instability & Disease · doi:10.1007/s42764-024-00139-3 · Cited by 1 · see citing works
“The tumor suppressor protein BRCA1 plays a pivotal role in the repair of DSBs through homologous recombination (HR), which is a high-fidelity repair pathway (Rabl et al., 2019; Scully et al., 1997; Tarsounas & Sung, 2020; Wang, 2012; Xia et al., 2006).”
Biomarker Discovery with Text Mining and Literature Based Discovery
Zhu, F., & Shen, B. (2013) · Translational bioinformatics · doi:10.1007/978-94-007-7975-4_4
A New Cell-Free System to Study BRCA1 Function
Walter, J. C., & Diamond, B. (2014) · Defense Technical Information Center (DTIC) · doi:10.21236/ada608618
Carr, A. M. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734831207.793557450
DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1
Leung, J. W. C., & Miller, K. M. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.09.008
Differential Remodeling of the BRCA1 Interactome by a Unique Minimal Clinical Truncation MutationPreprint
Chen, J., Sardiu, M. E., Rekowski, M. J., Nde, J., Clark, Z., Anant, S., Washburn, M. P., & Jensen, R. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.26.625539
The role of Alu elements in causing BRCA1 structural variation and breast cancer susceptibility
Yu, M., Jo, D., Shin, W., & Han, K. (2025) · Genes & Genomics · doi:10.1007/s13258-025-01708-w
“If a structural variant deletes this region, the resulting BRCA1 protein cannot assemble the homologous recombination (HR) repair complex with RAD51, BRCA2, and PALB2, impairing HR-mediated DSB repair (Hu et al. 2011; Krais et al. 2021; Wang 2012).”
Bellat, V., Verchère, A., Ashe, S. A., & Law, B. (2020) · Figshare · doi:10.6084/m9.figshare.12667617
Bellat, V., Verchère, A., Ashe, S. A., & Law, B. (2020) · Figshare · doi:10.6084/m9.figshare.12667620
Domain-specific Analysis of BRCA1 Variants Revealed Enrichment of G → T and C → A TransversionsPreprint
Beura, P. K., Singh, J., Satapathy, S. S., Varma, A. K., & Ray, S. K. (2026) · Research Square · doi:10.21203/rs.3.rs-8886029/v1
Copy number variants in BRCA1 and BRCA2 genes in Polish patients with breast and ovarian cancer
Doraczyńska-Kowalik, A., Matkowski, R., Michalowska, D., Chrusciel, A., Semeniuk, M., Blomka, D., Lawicka, P., Czykalko, E., Abrahamowska, M., Pietron, A., et al. (2026) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-026-06527-4
Villalobos-Valencia, R., Alvizo-Rodríguez, C. R., Carrasco‐Carballo, A., Sierra-Ramírez, J. A., López-Vázquez, U., Seseña, E., & Hernández-Caballero, M. E. (2026) · ACS Omega · doi:10.1021/acsomega.6c01546
Riguene, E., Thanassoulas, A., Alabdulrazzak, A., Al-Maraghi, S., Al-louzi, T., Alzneika, S., Fetais, S., Al-Khal, N., Farsi, H. F. A., & Nomikos, M. (2026) · Protein and Peptide Letters · doi:10.1016/j.ppl.2026.09.001
Dinh, H. H., Jasper, A. M., Baudin, A., Sung, P., & Libich, D. S. (2026) · Biomolecular NMR Assignments · doi:10.1007/s12104-026-10277-2
“C complexes, respectively (Wang 2012), which mediate recruitment of BRCA1 to sites of DNA damage and promote the early steps of HR-mediated DNA repair (Cruz-Garcia et al. 2014; Zou et al. 2014; Wu et al. 2016).”
- Authors
- Wang, B.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Wang, Bin
- ORCID
- Wang, Bin
- Venue
- Cell & Bioscience
- Published
- 2012
- Volume
- 2
- Issue
- 1
- Pages
- 6
- ISSN
- 2045-3701 (ISSN-L)
- PMC
- PMC3315748
- OpenAlex
- W2035903949
- Cited by
- 78
- References
- 123
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 10 · 2023: 6 · 2022: 4 · 2021: 7 · 2020: 6 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 4 · 2014: 4 · 2013: 8 · 2012: 6
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Cell & Bioscience (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (R01CA155025, CA155025)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, BRCT domain, germline mutations, breast cancer, ovarian cancer, DNA damage response, genome stability, phosphopeptide binding, Abraxas, BACH1, CtIP, cell cycle checkpoints, DNA repair, tumor suppressor function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review